Meropenem 1 GM Injection IP- MORPEX 1 GM

Meropenem 1 GM Injection IP – Advanced Carbapenem Therapy for resistant bacteria.

MORPEX 1GM – Meropenem Injection IP is a broad-spectrum carbapenem antibiotic designed to combat severe bacterial infections. By inhibiting bacterial cell wall synthesis, it exerts a potent bactericidal effect, leading to bacterial cell death. It remains highly stable against β-lactamase-producing bacteria, including extended-spectrum β-lactamases (ESBL), making it a reliable choice for treating resistant infections.
Meropenem Injection IP is widely used in critical care settings, delivering rapid and effective results in life-threatening infections.

Recommended by Specialists:
✅Dermatologists – For managing severe skin and soft tissue infections.
✅Pulmonologists – For treating serious respiratory infections, including pneumonia and ventilator-associated pneumonia.
✅Urologists – For prevention and treatment of complicated urinary tract infections.

Key Benefits of Meropenem 1 GM Injection IP- IPMORPEX 1 GM:
✅Broad-Spectrum Activity – Effectively targets Gram-positive, Gram-negative, and anaerobic bacteria, making it suitable for poly-microbial infections.
✅Potent Bactericidal Action – Rapidly kills bacteria by inhibiting cell wall synthesis.
✅Enhanced Safety Profile – Well-tolerated with minimal adverse effects, making it ideal for critically ill patients.
✅Β-Lactamase Resistance – Stable against most β-lactamase enzymes, ensuring efficacy in drug-resistant infections.

Indications:
✅Severe respiratory tract infections (e.g., pneumonia, including ventilator-associated pneumonia)
✅Complicated intra-abdominal infections
✅Complicated urinary tract infections
✅Bacterial meningitis
✅Skin and soft tissue infections
✅Sepsis and septic shock
✅Infections caused by multidrug-resistant organisms